| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $96.77B | +18.8% |
| Cost of Revenue | $79.11B | +30.5% |
| Gross Profit | $17.66B | -15.3% |
| R&D Expense | $3.97B | +29.1% |
| SG&A Expense | $4.80B | +21.6% |
| Operating Income | $8.89B | -34.9% |
| Interest Expense | $156.0M | -18.3% |
| Pre-tax Income | $9.97B | -27.3% |
| Income Tax | -$5.00B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.40B | +0.9% |
| Short-term Investments | $12.70B | +114.0% |
| Accounts Receivable | $3.51B | +18.8% |
| Inventory | $13.63B | +6.1% |
| Current Assets | $49.62B | +21.3% |
| Total Assets | $106.62B | +29.5% |
| Current Liabilities | $28.75B | +7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.26B | -10.0% |
| Capital Expenditures | $8.90B | +24.3% |
| Investing Cash Flow | -$15.58B | -30.2% |
| Financing Cash Flow | $2.59B | +173.4% |
| Free Cash Flow | $4.36B | -42.4% |
| -541.8% |
| Net Income | $15.00B | +19.4% |
| EPS (Basic) | $4.73 | +17.7% |
| EPS (Diluted) | $4.30 | +18.8% |
| Long-term Debt |
| $2.68B |
| +160.6% |
| Total Liabilities | $43.01B | +18.0% |
| Stockholders' Equity | $62.63B | +40.1% |